Proactive Investors - Run By Investors For Investors

Zelda Therapeutics closing in on development of autism clinical trial

Dr Stewart Washer, executive director of Zelda Therapeutics Ltd (ASX:ZLD), discusses with Proactive the successful results from their recent observation autism trial in Chile.

The results showed that in a group of 21 patients cannabis extracts were significantly more effective than conventional medicines used, including atypical antipsychotics, and these extracts were well tolerated by the patients overall.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
Meet West Wits Mining Limited and Global Energy Ventures Ltd at our event, Melbourne , 04 June 2019. Register here »
View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use